Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes

American Journal of Medicine

Volumn 119, Issue 3, 2006, Pages 248-254

  Han, Jin H ^a,d   Chandra, Abhinav ^b   Mulgund, Jyotsna ^b,c   Roe, Matthew T ^b,c   Peterson, Eric D ^b,c   Szczech, Lynda A ^b,c   Patel, Uptal ^b,c   Ohman, E Magnus ^e   Lindsell, Christopher J ^a   Gibler, W Brian ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e NONE

Author keywords

Acute coronary syndromes; Chronic kidney disease; Guidelines; Quality improvement

Indexed keywords

ABCIXIMAB; ACETYLSALICYLATE COPPER; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; INVASIVE PROCEDURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TRANSFUSION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTICENTER STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX;

EID: 32844463559     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.08.057     Document Type: Article

References (38)

1. C.A. Herzog, J.Z. Ma, A.J. Collins Poor long-term survival after acute myocardial infarction among patients on long-term dialysis N Engl J Med 339 1998 799 805
2. J.N. Beattie, S.S. Soman, K.R. Sandberg Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction Am J Kidney Dis 37 2001 1191 1200
3. R.S. Wright, G.S. Reeder, C.A. Herzog Acute myocardial infarction and renal dysfunction a high-risk combination Ann Intern Med 137 2002 563 570
4. G.M. Chertow, S.L. Normand, L.R. Silva, B.J. McNeil Survival after acute myocardial infarction in patients with end-stage renal disease results from the cooperative cardiovascular project Am J Kidney Dis 35 2000 1044 1051
5. R.V. Freeman, R.H. Mehta, W. Al Badr Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors J Am Coll Cardiol 41 2003 718 724
6. M.G. Shlipak, P.A. Heidenreich, H. Noguchi Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients Ann Intern Med 137 2002 555 562
7. C.R. Walsh, C.J. O'Donnell, C.A. Camargo Jr Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction Am Heart J 144 2002 1003 1011
8. N.S. Anavekar, J.J. McMurray, E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
9. J.J. Santopinto, K.A. Fox, R.J. Goldberg Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes findings from the global registry of acute coronary events (GRACE) Heart 89 2003 1003 1008
10. E. Braunwald, E.M. Antman, J.W. Beasley ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
11. A.S. Levey, T. Green, J.W. Kusek A simplified equation to predict glomerular filtration rate from serum creatinine a new prediction equation (Abstract) J Am Soc Nephrol 11 2000 A0828
12. S.L. Zeger, K.Y. Liang, P.S. Albert Models for longitudinal data a generalized estimating equation approach Biometrics 44 1988 1049 1060
13. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 1998 S112 S119
14. C. deFilippi, S. Wasserman, S. Rosanio Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis JAMA 290 2003 353 359
15. C. Lowbeer, P. Stenvinkel, R. Pecoits-Filho Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality J Intern Med 253 2003 153 160
16. M. Hausberg, M. Kosch, P. Harmelink Sympathetic nerve activity in end-stage renal disease Circulation 106 2002 1974 1979
17. P.A. McCullough, R.M. Nowak, C. Foreback Emergency evaluation of chest pain in patients with advanced kidney disease Arch Intern Med 162 2002 2464 2468
18. D. Mezzano, R. Tagle, O. Panes Hemostatic disorder of uremia the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis Thromb Haemost 76 1996 312 321
19. P.A. McCullough, K.R. Sandberg, S. Borzak Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease Am Heart J 144 2002 226 232
20. A.K. Berger, S. Duval, H.M. Krumholz Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction J Am Coll Cardiol 42 2003 201 208
21. J.L. Januzzi Jr, S.M. Snapinn, P.M. DiBattiste Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Circulation 105 2002 2361 2366
22. D.N. Reddan, J.C. O'Shea, I.J. Sarembock Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial) Am J Cardiol 91 2003 17 21
23. S.A. Spinler, S.M. Inverso, M. Cohen Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment analysis from the ESSENCE and TIMI 11B studies Am Heart J 146 2003 33 41
24. P.J. Best, R. Lennon, H.H. Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
25. B.A. Bartholomew, K.J. Harjai, S. Dukkipati Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification Am J Cardiol 93 2004 1515 1519
26. H.M. Sadeghi, G.W. Stone, C.L. Grines Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 108 2003 2769 2775
27. E.C. Keeley, R. Kadakia, S. Soman Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes Am J Cardiol 92 2003 509 514
28. M.H. Rubenstein, L.C. Harrell, B.V. Sheynberg Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 102 2000 2966 2972
29. L.A. Szczech, D.N. Reddan, W.F. Owen Differential survival after coronary revascularization procedures among patients with renal insufficiency Kidney Int 60 2001 292 299
30. C.A. Herzog, J.Z. Ma, A.J. Collins Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes Circulation 106 2002 2207 2211
31. B.R. Hemmelgarn, D. Southern, B.F. Culleton Survival after coronary revascularization among patients with kidney disease Circulation 110 2004 1890 1895
32. J.L. Januzzi, C.P. Cannon, P.M. DiBattiste Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial) Am J Cardiol 90 2002 1246 1249
33. I. Goldenberg, M. Shechter, S. Matetzky Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography A randomized controlled trial and review of the current literature Eur Heart J 25 2004 212 218
34. G.J. Merten, W.P. Burgess, L.V. Gray Prevention of contrast-induced nephropathy with sodium bicarbonate a randomized controlled trial JAMA 291 2004 2328 2334
35. F.S. Apple, M.M. Murakami, L.A. Pearce, C.A. Herzog Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease Circulation 106 2002 2941 2945
36. T.R. Green, T.A. Golper, R.D. Swenson Diagnostic value of creatine kinase and creatine kinase MB isoenzyme in chronic hemodialysis patients a longitudinal study Clin Nephrol 25 1986 22 27
37. J.S. Fernandez, B.T. Sadaniantz, A. Sadaniantz Review of antithrombotic agents used for acute coronary syndromes in renal patients Am J Kidney Dis 42 2003 446 455
38. Physicians' Desk Reference 58th ed. 2004 Thomson PDR Montvale, NJ